Stomorgyl film-coated tablets

Boehringer Ingelheim AH USA

Revision date : 2023-04-13

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
GHS08
Health risk rating 5
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

9005-25-8

Name of the chemical

Starch

Concentration

>=30-<50

EC/CAS

1344-28-1

Name of the chemical

aluminium oxide

Concentration

>=1-<5

General Information

Version

1.0

Revision date

2023-04-13

Product name

Stomorgyl film-coated tablets

Product Synonyms

Stomorgyl® 2 Film-Coated Tablets, Stomorgyl® 10 Film- Coated Tablets, Stomorgyl® 20 Film-Coated Tablets, Suanatem® Forte with active ingredient: Spiramycin and Metronidazole

1.2.1 Relevant identified uses

Veterinary product

1.2.2. Uses advised against

Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage

supplier name

Boehringer Ingelheim AH USA

Emergency telephone

+1 703-527-3887, +1 703-741-5970

Icons in SDS

GHS08 M004 M009 M010 M011 M017 M059

Company Information

company name

Boehringer Ingelheim AH USA

e-mail address of the competent person responsible for the Safety Data Sheet

EHS-Services@Boehringer-Ingelheim.com

GHS Information

Signal word

Danger

Hazard Codes

Hazard statements (CLP)

H317, H319, H334, H341, H351, H360, H372

Hazard statements

Code

Statements

H317

May cause an allergic skin reaction

H319

Causes serious eye irritation

H334

May cause allergy or asthma symptoms or breathing difficulties if inhaled

H341

Suspected of causing genetic defects

H351

Suspected of causing cancer

H360

May damage fertility or the unborn child

H372

Causes damage to organs through prolonged or repeated exposure

Section 2

SECTION 2: Hazards identification

Signal word

Danger

Hazard statements

H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H334 May cause allergy or asthma symptoms or breathing diffi- culties if inhaled. H341 Suspected of causing genetic defects. H351 Suspected of causing cancer. H360 May damage fertility or the unborn child. H372 Causes damage to organs (Central nervous system) through prolonged or repeated exposure.

Prevention

P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P272 Contaminated work clothing must not be allowed out of the workplace. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P285 In case of inadequate ventilation wear respiratory protec- tion.

Response

P302 + P352 IF ON SKIN: Wash with plenty of soap and water. P304 + P341 IF INHALED: If breathing is difficult, remove per- son to fresh air and keep comfortable for breathing. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P333 + P313 If skin irritation or rash occurs: Get medical advice/ P337 + P313 If eye irritation persists: Get medical advice/ atten- P342 + P311 If experiencing respiratory symptoms: Call a POISON CENTER/ doctor. P363 Wash contaminated clothing before reuse.

Storage

P405 Store locked up.

Disposal

P501 Dispose of contents/ container to an approved waste dis- posal plant.

2.3 Other hazards

This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet). This product does not contain titanium dioxide in its respirable form and would not be considered carcinogenic; however, upon crushing, grinding or other processing that could result in the gener- ation of respirable particulates, the Category 2 carcinogenic classification would apply.

2.1 Classification of the substance or mixture

1910.1200) Eye irritation : Category 2A Respiratory sensitisation : Category 1 Skin sensitisation : Category 1 Germ cell mutagenicity : Category 2 Carcinogenicity : Category 2 Reproductive toxicity : Category 1B Specific target organ toxicity : Category 1 (Central nervous system) - repeated exposure

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.